Healthcare · Pharmaceutical expenditure
Indonesia's pharmaceutical spending stands at just 0.85 % GDP% of GDP in 2026, one of the lowest rates in Southeast Asia. The country focuses on developing generic drug production in West Java's industrial zones, yet imports of active pharmaceutical ingredients still strain the budget. The 132nd rank out of 197 highlights that healthcare here is largely financed out-of-pocket.
Data for 2026 · unit: % GDP
Position
#132 / 197
Indonesia world ranking
Country position on the scale from last to first place for this indicator.
ID
#132
#197#1
Trend
Change over time
Change in indicator over the available period.
0.50
1990
0.60
2000
0.70
2010
0.80
2020
0.85
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Indonesia stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Indonesia — how much?
Based on 2026 data — 0.85 % GDP. This is rank #132 out of 197 countries.
What is Indonesia's rank by Pharmaceutical expenditure?
Indonesia ranks #132 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Indonesia?
Over the available period the indicator changed from 0.50 to 0.85 % GDP.